Technology area: Biotechnology & Pharmaceuticals
51 pending office actions • 43 art units • 50 examiners • 0 of 51 (0%) have an AI response strategy ready • 48 patents granted in the last 365 days
Rutgers, The State University of New Jersey has 51 pending office actions in Biotechnology & Pharmaceuticals. The portfolio spans 50 distinct examiners and 42 distinct art units, reflecting wide distribution across technical and examiner assignments. The near one-to-one relationship between actions and examiners means that repeated examiner-specific patterns are limited.
ROGERS, JAMES WILLIAM is the busiest examiner, with 2 pending matters. Those matters can support a focused comparison, but the broader portfolio calls for centralized tracking of deadlines and claim themes rather than reliance on one examiner strategy. Art-unit variation also makes application-specific prior-art and written-description analysis important.
Based on the USPTO statutory response window for each pending office action. 16 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 16 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 8 (16%) |
| §103 only | 17 (33%) |
| §102 only | 3 (6%) |
| §112 only | 3 (6%) |
| Double-patenting + other | 3 (6%) |
| Multi-statute (no §101) | 17 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROGERS, JAMES WILLIAM | 2 | 46.1% | +22.4% |
| COHEN, STEFANIE J | 1 | 75.5% | +2.5% |
| WEBB LYTTLE, ADRIENA JONIQUE | 1 | 13.3% | +66.7% |
| JACKSON III, WALTER | 1 | 50.0% | +0.0% |
| SALVUCCI, MATTHEW D | 1 | 72.4% | +27.1% |
| FARDANESH, MARJAN | 1 | 72.6% | +19.0% |
| COOK, WILLIAM J | 1 | 86.2% | +11.0% |
| THUESON, HANNA MARIE | 1 | 76.7% | +28.2% |
| CHERN, CHRISTINA | 1 | 39.1% | +41.5% |
| GRASER, JENNIFER E | 1 | 76.8% | +23.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18934468 | ELASTIC ROBOT PLATFORM FOR CLEANING AND SCRUBBING WITH TENDON-DRIVEN JOINTS | COOK, WILLIAM J | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18571127 | SYNTHETIC ECHO FROM ECG | NG, JONATHAN K | 119d overdue |
| 18571143 | RISK STRATIFICATION INTEGRATING MHEALTH AND AI | D ABREU, MICHAEL JOSEPH | 31d overdue |
| 17611241 | HIGH CONCENTRATION CELL PACKAGING AND SHIPPING | TRAN, KHOA NHAT | 6d |
| 18484001 | MICRORNA COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF NERVOUS SYSTEM DYSFUNCTION | TATGE, LEXUS MARC | 7d |
| 17432177 | LIF THERAPY FOR INDUCING INTESTINAL EPITHELIAL CELL REGENERATION | XIE, XIAOZHEN | 12d |
| 18528873 | NANOPARTICLE (NP) COMPOSITIONS AND METHODS OF USE THEREOF | AL-AWADI, DANAH J | 41d |
| 18384056 | SUPER-REGENERATIVE OSCILLATOR INTEGRATED METAMATERIAL LEAKY WAVE ANTENNA FOR MULTI-TARGET MOTION DETECTION AND RANGING | SABOKTAKIN, MARJAN | 77d |
| 19106886 | SUCTION TOOTHBRUSH AND RELATED METHODS | WEBB LYTTLE, ADRIENA JONIQUE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17898995 | MASKED FLUOROGENIC COMPOUNDS AND METHODS OF USING THE SAME | ROGERS, JAMES WILLIAM | 26d |
| 19106886 | SUCTION TOOTHBRUSH AND RELATED METHODS | WEBB LYTTLE, ADRIENA JONIQUE | — |
| 18996566 | OBJECT DETECTION AND IMAGE SEGMENTATION FOR EUKARYOTIC CELLS | SALVUCCI, MATTHEW D | — |
| 18869522 | TECHNIQUES FOR MEASURING ATYPICAL NEURODEVELOPMENT IN NEONATES BASED ON AUDITORY BRAINSTEM RESPONSE (ABR) TESTS | FARDANESH, MARJAN | — |
| 18934468 | ELASTIC ROBOT PLATFORM FOR CLEANING AND SCRUBBING WITH TENDON-DRIVEN JOINTS | COOK, WILLIAM J | — |
| 18855043 | piRNA-BASED CONSTRUCTS FOR REGULATING GENE EXPRESSION AND METHODS OF USE THEREOF | THUESON, HANNA MARIE | — |
| 18899897 | SMALL ANGLE TILTING TO APPROXIMATE VERTICAL SOLAR ARRAYS AND PROVIDE ENHANCED ENERGY YIELD | CHERN, CHRISTINA | — |
| 18845468 | ATTENUATED MATURATION-DEFECTIVE CHLAMYDIA VACCINES | GRASER, JENNIFER E | — |
| Art Unit | Apps |
|---|---|
| 1638 | 2 |
| 1626 | 2 |
| 2145 | 2 |
| 1619 | 2 |
| 1682 | 2 |
| 1672 | 2 |
| 1618 | 2 |
| 3772 | 1 |
| 2613 | 1 |
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19232930 | THICKNESS-LIMITED ELECTROSPRAY DEPOSITION | COHEN, STEFANIE J | — | §102 | Non-Final OA | — | Pending | Jun 10, 2025 |
| 19106886 | SUCTION TOOTHBRUSH AND RELATED METHODS | WEBB LYTTLE, ADRIENA JONIQUE | 3772 | §102§103 | Non-Final OA | — | Pending | Feb 26, 2025 |
| 18997744 | TGFB TREATMENT OF ORGANOID CULTURES TO PRIME FOR REGENERATIVE THERAPY OF DAMAGED GI EPITHELIA | JACKSON III, WALTER | 1638 | §103 | Non-Final OA | — | Pending | Jan 22, 2025 |
| 18996566 | OBJECT DETECTION AND IMAGE SEGMENTATION FOR EUKARYOTIC CELLS | SALVUCCI, MATTHEW D | 2613 | §103 | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18869522 | TECHNIQUES FOR MEASURING ATYPICAL NEURODEVELOPMENT IN NEONATES BASED ON AUDITORY BRAINSTEM RESPONSE (ABR) TESTS | FARDANESH, MARJAN | 3791 | §103 | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18934468 | ELASTIC ROBOT PLATFORM FOR CLEANING AND SCRUBBING WITH TENDON-DRIVEN JOINTS | COOK, WILLIAM J | 3723 | §112 | Non-Final OA | — | Pending | Nov 01, 2024 |
| 18855043 | piRNA-BASED CONSTRUCTS FOR REGULATING GENE EXPRESSION AND METHODS OF USE THEREOF | THUESON, HANNA MARIE | 1638 | §102§103 | Non-Final OA | — | Pending | Oct 08, 2024 |
| 18899897 | SMALL ANGLE TILTING TO APPROXIMATE VERTICAL SOLAR ARRAYS AND PROVIDE ENHANCED ENERGY YIELD | CHERN, CHRISTINA | 1722 | §102§103§112 | Final Rejection | — | Pending | Sep 27, 2024 |
| 18845468 | ATTENUATED MATURATION-DEFECTIVE CHLAMYDIA VACCINES | GRASER, JENNIFER E | 1645 | §102§103§112 | Non-Final OA | — | Pending | Sep 10, 2024 |
| 18782246 | SPATIAL MODULATION-BASED ORTHOGONAL SIGNAL DIVISION MULTIPLEXING COMMUNICATIONS | SANDHU, AMRITBIR K | 2634 | §103 | Non-Final OA | — | Pending | Jul 24, 2024 |
| 18758924 | Compositions And Methods Targeting G12 Signaling For Bronchodilator Therapy | COUGHLIN, MATTHEW P | 1626 | §103Other | Final Rejection | 13d | Pending | Jun 28, 2024 |
| 18654839 | COLD TOLERANT BASIL VARIETIES | STEPHENS, REBECCA JOHANNA | 1663 | §102§112 | Non-Final OA | — | Pending | May 03, 2024 |
| 18648062 | THERAPEUTIC COMPOUNDS | CORNET, JEAN P | 1628 | §102§103§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18638356 | METHODS AND SYSTEMS FOR IMPROVED ANOMALY IDENTIFICATION THROUGH PRIVACY-ENHANCED TWO-STEP FEDERATED LEARNING | JUNG, DONG YOON | 2145 | §101§103 | Non-Final OA | — | Pending | Apr 17, 2024 |
| 18631821 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY CONDITIONS | OLSON, ANDREA STEFFEL | 1693 | §102§103§112 | Non-Final OA | — | Pending | Apr 10, 2024 |
| 18700140 | IMPROVED CEREBRAL ANGIOGRAPHY CATHETER | FERNANDEZ, KATHERINE L | 3798 | §103 | Non-Final OA | — | Pending | Apr 10, 2024 |
| 18699103 | FLAVONOID DERIVATIVES WITH GABAA RECEPTOR ACTIVITY AND METHODS OF USE | SHIM, DAVID M. | 1626 | §102§112 | Non-Final OA | — | Pending | Apr 05, 2024 |
| 18696883 | CELLULARIZED NERVE REGENERATION GRAFT AND METHODS OF MAKING THE SAME | BROWE, DAVID | 1617 | §103§112 | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18618677 | HIGH EFFICIENCY MICROFLUIDIC BIOBARRIER PLATFORM, SYSTEM, AND METHOD | BRIDGES, DONAVAN LEE | 1758 | §102§103 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18613765 | METHODS AND SYSTEMS FOR IMPROVED FEDERATED LEARNING AND IMPLEMENTATIONS THEREOF | MESFIN, MATTHEWOS | 2145 | §103 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18442811 | ULTRA-LOW POWER ANALOG NEURAL NETWORKS | SPRATT, BEAU D | 2143 | §103 | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18683583 | DUAL-TARGETED RNA POLYMERASE INHIBITORS: CONJUGATES OF BENZOXAZINO- AND SPIRO-RIFAMYCINS WITH N ALPHA-AROYL-N-ARYL-PHENYLALANINAMIDES | SEITZ, ANTHONY JOSEPH | 1629 | §103§112Other | Non-Final OA | — | Pending | Feb 14, 2024 |
| 18573813 | COMPOUNDS FOR MODULATING MYCOBACTERIUM TUBERCULOSIS RESPONSE | CHANDRAKUMAR, NIZAL S | 1625 | §112 | Final Rejection | — | Pending | Dec 22, 2023 |
| 18571143 | RISK STRATIFICATION INTEGRATING MHEALTH AND AI | D ABREU, MICHAEL JOSEPH | 3796 | §101§102 | Final Rejection | 31d overdue | Pending | Dec 15, 2023 |
| 18571083 | CONTINOUS IMPREGNATION OF ACTIVE PHARMACEUTICAL INGREDIENTS ONTO POROUS CARRIERS | GOTFREDSON, GAREN | 1619 | §102§103Other | Final Rejection | — | Pending | Dec 15, 2023 |
| 18571127 | SYNTHETIC ECHO FROM ECG | NG, JONATHAN K | 3619 | §101§102§103 | Final Rejection | 119d overdue | Pending | Dec 15, 2023 |
| 18528873 | NANOPARTICLE (NP) COMPOSITIONS AND METHODS OF USE THEREOF | AL-AWADI, DANAH J | 1615 | §102§103§112Other | Final Rejection | 41d | Pending | Dec 05, 2023 |
| 18529611 | METHODS FOR TREATING LYSOSOMAL STORAGE DISEASES | EIX, EMILY FAY | 1653 | §102§103DP | Non-Final OA | — | Pending | Dec 05, 2023 |
| 18289859 | A Genotypic Assay To Subspeciate Mycobacterium Abscessus Complex Strains And Determine Macrolide Resistance | GRAY, JESSICA | 1682 | §101§103 | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18384056 | SUPER-REGENERATIVE OSCILLATOR INTEGRATED METAMATERIAL LEAKY WAVE ANTENNA FOR MULTI-TARGET MOTION DETECTION AND RANGING | SABOKTAKIN, MARJAN | 3797 | §102§103§112 | Non-Final OA | 77d | Pending | Oct 26, 2023 |
| 18287763 | METHODS TO ANALYZE HOST-MICROBIOME INTERACTIONS AT SINGLE-CELL AND ASSOCIATED GENE SIGNATURES IN CANCER | KASSA, TIGABU | 1619 | §103 | Final Rejection | — | Pending | Oct 20, 2023 |
| 18287776 | IDENTIFYING MICROBIAL SIGNATURES AND GENE EXPRESSION SIGNATURES | MYERS, CARLA J | 1682 | §101§103§112Other | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18381416 | MONITORING VITAL SIGNS OF MULTIPLE PERSONS VIA SINGLE PHASED-MIMO RADAR | MAKHDOOM, SAMARINA | 3648 | §103 | Non-Final OA | 82d | Pending | Oct 18, 2023 |
| 18484001 | MICRORNA COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF NERVOUS SYSTEM DYSFUNCTION | TATGE, LEXUS MARC | 1637 | §101§102§103§112DP | Final Rejection | 7d | Pending | Oct 10, 2023 |
| 18244493 | ENERGY HARVESTING OF INFRASTRUCTURE VIBRATIONS | GONZALEZ, JULIO CESAR | 2831 | §103 | Non-Final OA | — | Pending | Sep 11, 2023 |
| 18278932 | STERICALLY HINDERED N-ALIPHATIC N-HETEROCYCLIC CARBENE CATALYSTS AND METHODS USING SAME | MERKLING, SALLY ANNE | 1738 | §102 | Non-Final OA | 22d | Pending | Aug 25, 2023 |
| 18278947 | UNSYMMETRICAL N-HETEROCYCLIC CARBENE CATALYSTS AND METHODS USING SAME | HUI, SAN MING R | 1627 | §102 | Final Rejection | 62d | Pending | Aug 25, 2023 |
| 18209943 | SAFE AGILE HAZARD AVOIDANCE SYSTEM FOR AUTONOMOUS VEHICLES | HERRERA, MICHAEL J | 3668 | §103 | Final Rejection | 79d overdue | Pending | Jun 14, 2023 |
| 18250779 | REPLICATION-DEFECTIVE VACCINES AND USES THEREOF | CHEN, STACY BROWN | 1672 | §103 | Final Rejection | — | Pending | May 05, 2023 |
| 18297470 | IDENTIFYING TREATMENT RESPONSE SIGNATURES | STRIEGEL, THEODORE CHARLES | 1685 | §101§103§112 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18124341 | Methods For Finding Genome Rearrangements From Sequencing Data | LEVERETT, MARY CHANG | 1672 | §101§112 | Non-Final OA | — | Pending | Mar 21, 2023 |
| 18005472 | BIOMARKERS FOR IDENTIFYING PATIENTS AT HIGH RISK OF PROGRESSING FROM BARRETT'S ESOPHAGUS TO ESOPHAGEAL ADENOCARCINOMA | POHNERT, STEVEN C | 1683 | §102§112 | Final Rejection | — | Pending | Jan 13, 2023 |
| 17906514 | CONTINUOUS MELT-COATING OF ACTIVE PHARMACEUTICAL INGREDIENTS USING SURFACTANTS FOR DISSOLUTION ENHANCEMENT | ARNOLD, ERNST V | 1613 | §103DP | Final Rejection | 23d overdue | Pending | Sep 16, 2022 |
| 17898995 | MASKED FLUOROGENIC COMPOUNDS AND METHODS OF USING THE SAME | ROGERS, JAMES WILLIAM | 1618 | §103 | Final Rejection | 26d | Pending | Aug 30, 2022 |
| 17822641 | Graphene-conductive polymer-coated, paper-based nano-biosensor for cytokine detection | SUN, CAITLYN MINGYUN | 1700 | §103 | Final Rejection | — | Pending | Aug 26, 2022 |
| 17791684 | COMPLEXES OF N-HETEROCYCLIC CARBENES FOR TRANSITION METAL CATALYSIS | CHEN, PO-CHIH | 1621 | §112 | Final Rejection | 27d | Pending | Jul 08, 2022 |
| 17757609 | METHODS FOR INHIBITION OF ALPHA-SYNUCLEIN mRNA USING SMALL MOLECULES | LEE, WILLIAM Y | 1623 | §103 | Final Rejection | 29d | Pending | Jun 17, 2022 |
| 17611241 | HIGH CONCENTRATION CELL PACKAGING AND SHIPPING | TRAN, KHOA NHAT | 1632 | §103§112 | Non-Final OA | 6d | Pending | Nov 15, 2021 |
| 17432177 | LIF THERAPY FOR INDUCING INTESTINAL EPITHELIAL CELL REGENERATION | XIE, XIAOZHEN | 1674 | §103§112 | Final Rejection | 12d | Pending | Aug 19, 2021 |
| 17234669 | Multi-Functional Infrared-Emitting Composites | ROGERS, JAMES WILLIAM | 1618 | §102§103DP | Non-Final OA | — | Pending | Apr 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRutgers, The State University of New Jersey has 51 pending office actions as of October 2026, spread across 43 art units and 50 examiners.
James William Rogers has the most, with 2 of Rutgers, The State University of New Jersey's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
